Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Modification of Ocular Defects in Mouse Developmental Glaucoma Models by Tyrosinase
Richard T. Libby,1*Richard S. Smith,12*Olga V. Savinova,2Adriana Zabaleta,2Janice E. Martin,12Frank J. Gonzalez,3Simon W. M. John124
Mutations in the cytochrome P450 family 1, subfamily B, polypeptide 1 (CYP1B1) gene are a common cause
of human primary congenitalglaucoma (PCG). Here we show that
Cyp1b1-/- mice have ocular drainage structure
abnormalities resemblingthose reported in human PCG patients. Using
Cyp1b1-/- mice, we identified the tyrosinase
gene (Tyr) as a modifier ofthe drainage structure
phenotype, with Tyr deficiency increasingthe magnitude of
dysgenesis. The severe dysgenesis in eyes lackingboth CYP1B1 and TYR
was alleviated by administration of the tyrosinaseproduct
dihydroxyphenylalanine (L-dopa). Tyr also
modified thedrainage structure dysgenesis in mice with a mutant
Foxc1 gene,which is also involved in PCG. These experiments
raise the possibilitythat a tyrosinase/L-dopa pathway
modifies human PCG, which couldopen new therapeutic avenues.
1 The Jackson Laboratory,
2 The Howard Hughes Medical Institute, Bar Harbor,
ME 04609, USA.
3 Laboratory of Metabolism, National
Cancer Institute, Bethesda, MD 20892, USA.
4 Department of Ophthalmology, Tufts University
School of Medicine, Boston, MA 02111, USA.
*
These authors contributed equally to this work.
To whom correspondence should be addressed. E-mail:
swmj{at}jax.org
The editors suggest the following Related Resources on Science sites:
In Science Magazine
PERSPECTIVES
Wallace L. M. Alward (7 March 2003) Science299 (5612), 1527.
[DOI: 10.1126/science.1082933] |Summary »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Expression of CYP1A1 and CYP1B1 in human endothelial cells: regulation by fluid shear stress.
D. E. Conway, Y. Sakurai, D. Weiss, J. D. Vega, W. R. Taylor, H. Jo, S. G. Eskin, C. B. Marcus, and L. V. McIntire (2009)
Cardiovasc Res
81, 669-677
|Abstract »|Full Text »|PDF »
CYP1B1 expression promotes the proangiogenic phenotype of endothelium through decreased intracellular oxidative stress and thrombospondin-2 expression.
Y. Tang, E. A. Scheef, S. Wang, C. M. Sorenson, C. B. Marcus, C. R. Jefcoate, and N. Sheibani (2009)
Blood
113, 744-754
|Abstract »|Full Text »|PDF »
Cyp1b1 Exerts Opposing Effects on Intestinal Tumorigenesis via Exogenous and Endogenous Substrates.
R. B. Halberg, M. C. Larsen, T. L. Elmergreen, A. Y. Ko, A. A. Irving, L. Clipson, and C. R. Jefcoate (2008)
Cancer Res.
68, 7394-7402
|Abstract »|Full Text »|PDF »
Role of AHR2 in the Expression of Novel Cytochrome P450 1 Family Genes, Cell Cycle Genes, and Morphological Defects in Developing Zebra Fish Exposed to 3,3',4,4',5-Pentachlorobiphenyl or 2,3,7,8-Tetrachlorodibenzo-p-dioxin.
M. E. Jonsson, M. J. Jenny, B. R. Woodin, M. E. Hahn, and J. J. Stegeman (2007)
Toxicol. Sci.
100, 180-193
|Abstract »|Full Text »|PDF »
Disease Gene Candidates Revealed by Expression Profiling of Retinal Ganglion Cell Development.
J. T. Wang, N. J. Kunzevitzky, J. C. Dugas, M. Cameron, B. A. Barres, and J. L. Goldberg (2007)
J. Neurosci.
27, 8593-8603
|Abstract »|Full Text »|PDF »
Cyp1b1 Protein in the Mouse Eye during Development: An Immunohistochemical Study.
D. Choudhary, I. Jansson, K. Rezaul, D. K. M. Han, M. Sarfarazi, and J. B. Schenkman (2007)
Drug Metab. Dispos.
35, 987-994
|Abstract »|Full Text »|PDF »
D. B. Gould, J. K. Marchant, O. V. Savinova, R. S. Smith, and S. W.M. John (2007)
Hum. Mol. Genet.
16, 798-807
|Abstract »|Full Text »|PDF »
Erythropoietin Promotes Survival of Retinal Ganglion Cells in DBA/2J Glaucoma Mice.
L. Zhong, J. Bradley, W. Schubert, E. Ahmed, A. P. Adamis, D. T. Shima, G. S. Robinson, and Y.-S. Ng (2007)
Invest. Ophthalmol. Vis. Sci.
48, 1212-1218
|Abstract »|Full Text »|PDF »
Simultaneous Fundus Imaging and Optical Coherence Tomography of the Mouse Retina.
O. P. Kocaoglu, S. R. Uhlhorn, E. Hernandez, R. A. Juarez, R. Will, J.-M. Parel, and F. Manns (2007)
Invest. Ophthalmol. Vis. Sci.
48, 1283-1289
|Abstract »|Full Text »|PDF »
Differential Expression Profile Prioritization of Positional Candidate Glaucoma Genes: The GLC1C Locus.
F. W. Rozsa, K. M. Scott, H. Pawar, J. R. Samples, M. K. Wirtz, and J. E. Richards (2007)
Arch Ophthalmol
125, 117-127
|Abstract »|Full Text »|PDF »
MicroRNA Regulates the Expression of Human Cytochrome P450 1B1..
Y. Tsuchiya, M. Nakajima, S. Takagi, T. Taniya, and T. Yokoi (2006)
Cancer Res.
66, 9090-9098
|Abstract »|Full Text »|PDF »
Research Opportunities in Vision: A Report of the U.S.-Indo Workshops on Collaborative Research.
D. Balasubramanian, P. L. Kaufman, and U.S.-Indo Collaborative Research Workshops Group (2006)
Invest. Ophthalmol. Vis. Sci.
47, 1717-1735
|Full Text »|PDF »
Of mice and men: tyrosinase modification of congenital glaucoma in mice but not in humans..
C. Bidinost, N. Hernandez, D. P. Edward, A. Al-Rajhi, R. A. Lewis, J. R. Lupski, D. W. Stockton, and B. A. Bejjani (2006)
Invest. Ophthalmol. Vis. Sci.
47, 1486-1490
|Abstract »|Full Text »|PDF »
Mechanistic Insights into Glaucoma Provided by Experimental Genetics The Cogan Lecture.
S. W. M. John (2005)
Invest. Ophthalmol. Vis. Sci.
46, 2650-2661
|Full Text »|PDF »
Potential Role for Human Cytochrome P450 3A4 in Estradiol Homeostasis.
A.-M. Yu, K. Fukamachi, K. W. Krausz, C. Cheung, and F. J. Gonzalez (2005)
Endocrinology
146, 2911-2919
|Abstract »|Full Text »|PDF »
Characterization of Common CYP1B1 Variants with Different Capacity for Benzo[a]pyrene-7,8-Dihydrodiol Epoxide Formation from Benzo[a]pyrene.
E. Aklillu, S. Ovrebo, I. V. Botnen, C. Otter, and M. Ingelman-Sundberg (2005)
Cancer Res.
65, 5105-5111
|Abstract »|Full Text »|PDF »
Intraocular Pressure in Zebrafish: Comparison of Inbred Strains and Identification of a Reduced Melanin Mutant with Raised IOP.
B. A. Link, M. P. Gray, R. S. Smith, and S. W. M. John (2004)
Invest. Ophthalmol. Vis. Sci.
45, 4415-4422
|Abstract »|Full Text »|PDF »
Progressive Glomerulonephritis and Histiocytic Sarcoma Associated with Macrophage Functional Defects in CYP1B1-Deficient Mice.
J. M. Ward, N. P. Nikolov, J. R. Tschetter, J. B. Kopp, F. J. Gonzalez, S. Kimura, and R. M. Siegel (2004)
Toxicol Pathol
32, 710-718
|Abstract »|PDF »
Defining the Pathogenicity of Optineurin in Juvenile Open-Angle Glaucoma.
C. E. Willoughby, L. L. Y. Chan, S. Herd, G. Billingsley, N. Noordeh, A. V. Levin, Y. Buys, G. Trope, M. Sarfarazi, and E. Heon (2004)
Invest. Ophthalmol. Vis. Sci.
45, 3122-3130
|Abstract »|Full Text »|PDF »
CYP1B1 mutations in French patients with early-onset primary open-angle glaucoma.
R Melki, E Colomb, N Lefort, A P Brezin, and H-J Garchon (2004)
J. Med. Genet.
41, 647-651
|Abstract »|Full Text »|PDF »
Essential structural and functional determinants within the forkhead domain of FOXC1.
R. A. Saleem, S. Banerjee-Basu, T. C. Murphy, A. Baxevanis, and M. A. Walter (2004)
Nucleic Acids Res.
32, 4182-4193
|Abstract »|Full Text »|PDF »
Correlations of Genotype with Phenotype in Indian Patients with Primary Congenital Glaucoma.
S. G. Panicker, A. K. Mandal, A. B. M. Reddy, V. K. Gothwal, and S. E. Hasnain (2004)
Invest. Ophthalmol. Vis. Sci.
45, 1149-1156
|Abstract »|Full Text »|PDF »